Nagi Bioscience
Saint-sulpice
About Nagi Bioscience
Nagi Bioscience aims to revolutionize the way toxic and/or beneficial effects of substances are tested today, by introducing the first “Organism-on-Chip” technology.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $18.3M
- Funding stage: Early Stage Venture
- Last round: Grant (Sep 2025)
- Website: nagibio.ch
- Phone: +41 21 693 48 34
Industries & Categories
Biotechnology, Life Science, Product Research
Social Profiles
Canonical: https://fsome.com/organization/nagi-bioscience-60485 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.